Status:
COMPLETED
A Study to Collect Information of People With Narcolepsy in Spain
Lead Sponsor:
Takeda
Conditions:
Narcolepsy
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to review information of people with a sleep condition called narcolepsy. Narcolepsy is a condition that causes extreme sleepiness during the day including falling asleep suddenly. Stu...
Detailed Description
This is a non-interventional, cross-sectional study with retrospective medical chart review conducted in public and private Spanish sleep clinics, to describe the management of adult participants diag...
Eligibility Criteria
Inclusion
- With confirmed diagnosis of narcolepsy defined by ICDS-3.
- With at least 1-year follow-up with data available at the participating site after initial narcolepsy diagnosis and before study inclusion.
- With data available at the participant site at least 1-year before first narcolepsy diagnosis.
- Capable to fulfill the study questionnaires.
Exclusion
- Participating in a clinical trial (less than or equal to \[\<=\] 12 months).
- With any serious degenerative disease (Alzheimer, Parkinson or epilepsy) or psychiatric condition.
Key Trial Info
Start Date :
February 18 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 4 2022
Estimated Enrollment :
214 Patients enrolled
Trial Details
Trial ID
NCT04667338
Start Date
February 18 2021
End Date
November 4 2022
Last Update
October 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clinic de Barcelona
Barcelona, Catalonia, Spain, 8036